|
Press Releases
July 2, 2007 - Elaine Richardson Joins Indigo Pharmaceuticals as Vice President of Clinical Operations
June 1, 2007 - Indigo Pharmaceuticals, Inc. Signs License Agreement for INDI-702, a Drug for the Treatment of Arteriosclerosis Obliterans, with Nissan Chemical Industries and Taisho Pharmaceutical Co.
Media
June 1, 2007 - Indigo Lincenses Vasodilator INDI-702 From Nissan/Taisho For Peripheral Artery Disease
|